Posts

Showing posts from May, 2013

EMBL - EBI: Scientific Training Officer, e-learning - Cambridge

Image
  Scientific Training Officer, e-learning   Location: EMBL-EBI, Hinxton, near Cambridge, UK Staff Category: Staff Member Contract Duration: 3 years Grading: 5 Closing Date: 26 June 2013 Reference number: EBI_00303 Job Description The European Bioinformatics Institute (EMBL-EBI), which is part of the European Molecular Biology Laboratory (EMBL) and is Europe's main provider of biological data to the life science research community, is looking for a Scientific Training Officer to maintain and develop its e-learning resource, Train online. Providing advanced bioinformatics training to scientists at all levels is one of the cornerstones of EMBL-EBI's mission, and you will join the Training Team which is responsible for coordinating EMBL-EBI's training activities and for raising awareness of EMBL-EBI's activities in general. The main focus will be on developing online training courses, in close collaboration with others at...

Novartis Institutes for BioMedical Research (US): Sr. Investigator, Oncology Biotherapeutics

The Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization for Novartis. The NIBR research network is comprised of more than 6,000 scientists, physicians, and business professionals working together across 10 locations around the world to discover innovative medicines that treat diseases with high unmet medical need. Novartis employs more than 2,000 associates in Cambridge, making it the city’s largest private employer and ideally situated in one of the leading life science communities in the world.  NIBR conducts research globally with sites in Emeryville, California; Cambridge, MA; East Hanover, NJ; Basel, Switzerland; Horsham, UK; and Shanghai, China. Description: We are seeking a highly motivated and innovative senior research investigator with demonstrated expertise in cancer immunology and a strong publication record to join a dynamic team dedicated to the discovery and development of novel biotherapeutics for cancer.  In...

Philip Morris International (PMI): Manager QA - Switzerland

Manager QA YOU are a highly motivated, passionate team player who is always committed to deliver work of the highest quality. You have a flexible, solution-oriented personality with an analytical mind that enjoys problem-solving. You have a strong customer focus and seek a creative and international work environment. THE OPPORTUNITY You will join the Quality Assurance (QA) team of Philip Morris Products S.A. in Neuchâtel, Switzerland and will be part of the PMI Research & Development Department, whose primary mission is to research and develop new products with the potential to reduce the risks of smoking-related diseases. You will develop and drive the implementation of a GxP-compliant Quality Management System (QMS) throughout PMI’s Research and Development (R & D) department. You will also manage the establishment and maintenance of a QA Unit to support clinical studies. Specifically, you will: • Support the establishment and maintenance of ...

Paramount Recruitment: Senior Regulatory Affairs Consultant

Image
Senior Regulatory Affairs Consultant - Cambridgeshire - Consultancy Experienced Regulatory Affairs professional wanted to join a dynamic consultancy in Cambridgeshire as a Senior Regulatory Affairs Consultant. This expanding and client focused company has a worldwide presence, it specializes in product development programs to help products from early concept stage through to the clinic. They offer services in Regulatory Affairs, Quality Assurance and early stage Clinical Research to Pharmaceutical, Biopharmaceutical and Biotechnology companies who are developing new drug substances, biotech/biological products, NCE's (New Chemical Entities) and abridged applications. As the Senior Regulatory Affairs Consultant you will report to the Head of Regulatory Affairs whilst providing regulatory consulting services such as project management and providing expert regulatory advice relating to CTA's and MAA's. Key responsibilities: ï‚§Prepare, review and submit regulatory applica...

SEC Recruitment: Quality Control Director

Image
Your responsabilities: *You manage the Quality control department organized in three teams: Raw Materials and Environment, Microbiology and Biochemistry *You provide an expertise in analytical tools development, validation and stability studies to match customer's and regulatory authorities' requirement *You are the quality control representative during regulatory authorities inspection and customers audits *You ensure adequate personal and equipment resources to support quality control activities in ongoing and future projects *You monitor project activities in your department and ensure a proper coordination with the other departments *You monitor the department's performance, improve the quality management system and work efficiency *You plan the yearly department budget and monitor status during the year *You maintain a state-of-the-art Quality Control platform through the development of new competences and technologies *You establish and communicate the depar...

Do no harm

Adoptive T-cell therapy (ACT) is now yielding promising data in human trials of advanced melanoma, lymphoma and several other difficult-to-treat cancers. It has taken decades to realize the goal of harnessing a patient's own T cells to seek and destroy tumor cells expressing particular antigens. But as newer-generation ACTs begin to generate impressive clinical data and attract breathless headlines, more researchers are entering the field and launching trials of their own. This means that nowâ€"more than everâ€"the field needs to take stock of how best to select the right T-cell targeting antigen. ACT involves isolating a patient's tumor-targeting T cells, activating and expanding them, and then injecting them back into the patient. Early trials used T lymphocytes isolated from resected tumors, but this worked well only for melanoma. To treat other types of tumors, researchers engineer T cells from patient peripheral blood to express high-affini...